Loading stock data…
Loading stock data…
US$8.69
Get one email when XERS crosses your level. Checked every 15 minutes during market hours.
▼ -0.01 (-0.11%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
70.2
OverboughtAbove 70 can signal overbought; below 30, oversold.
MACD
0.50
Bullish momentumMACD above its signal line (0.50).
50-day average
6.99
Price aboveShort-term trend reference.
200-day average
7.07
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Xeris Biopharma Holdings, Inc. is a biopharmaceutical company headquartered in Chicago, Illinois. It specializes in developing and commercializing therapies for chronic endocrine and neurological conditions, with a commercial portfolio featuring three key products: Recorlev for treating endogenous Cushing's syndrome in adults unsuitable for surgery, Gvoke for severe hypoglycemia, and Keveyis for Primary Periodic Paralysis. The company leverages proprietary XeriSol and XeriJect formulation platfo…
www.xerispharma.com5 strong buy · 6 buy · 2 hold · 0 sell · 0 strong sell (13 analysts, 2026-07-01)
5 strong buy · 6 buy · 2 hold · 0 sell · 0 strong sell (13 analysts, 2026-06-01)
5 strong buy · 6 buy · 2 hold · 0 sell · 0 strong sell (13 analysts, 2026-05-01)
5 strong buy · 6 buy · 2 hold · 0 sell · 0 strong sell (13 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-07 | — | 0.01 | — |
| 2026-03-02 | 0.05 | 0.06 | ✓ Beat |
| 2026-02-20 | 1.57 | 1.5 | ✗ Miss |
| 2026-01-28 | 1.03 | 1.03 | ✓ Beat |
| 2025-10-08 | 0.04 | 0.04 | ✓ Beat |
| 2025-08-07 | -0.03 | -0.01 | ✓ Beat |
| 2025-05-08 | -0.04 | -0.06 | ✗ Miss |
| 2025-03-06 | -0.02 | -0.03 | ✗ Miss |
Companies in the same industry, via Finnhub